Viral infections continue to represent major challenges to public health, and an enhanced mechanistic understanding of the processes that contribute to viral life cycles is necessary for the development of new therapeutic strategies 1 . Viperin, a member of the radical S-adenosyl-l-methionine (SAM) superfamily of enzymes, is an interferon-inducible protein implicated in the inhibition of replication of a broad range of RNA and DNA viruses, including dengue virus, West Nile virus, hepatitis C virus, influenza A virus, rabies virus 2 and HIV 3,4 . Viperin has been suggested to elicit these broad antiviral activities through interactions with a large number of functionally unrelated host and viral proteins 3,4 . Here we demonstrate that viperin catalyses the conversion of cytidine triphosphate (CTP) to 3ʹ-deoxy-3′,4ʹ-didehydro-CTP (ddhCTP), a previously undescribed biologically relevant molecule, via a SAMdependent radical mechanism. We show that mammalian cells expressing viperin and macrophages stimulated with IFNα produce substantial quantities of ddhCTP. We also establish that ddhCTP acts as a chain terminator for the RNA-dependent RNA polymerases from multiple members of the Flavivirus genus, and show that ddhCTP directly inhibits replication of Zika virus in vivo. These findings suggest a partially unifying mechanism for the broad antiviral effects of viperin that is based on the intrinsic enzymatic properties of the protein and involves the generation of a naturally occurring replication-chain terminator encoded by mammalian genomes.
single quantum coherence (2D HSQC) chemical-shift analysis and 31 P NMR analysis on natural abundance viperin product were performed (see Supplementary Information for details, Extended Data Figs. 1d, 2; see Supplementary Table 1 for chemical-shift data). Taken together, all available NMR and mass spectrometry data are consistent with the rVIP-catalysed conversion of CTP to ddhCTP, in which dehydration-involving the loss of both the 4ʹ hydrogen and the 3ʹ hydroxyl group-occurs without rearrangement of the carbon skeleton. It is notable that MoaA, which catalyses the conversion of GTP to (8S)-3′,8-cyclo-7,8-dihydroguanosine 5′-triphosphate 5 , is the enzyme with the highest sequence similarity to viperin for which an unambiguous functional annotation exists. Additionally, the recent report of the structure of viperin from Mus musculus proposed that the presumptive catalytic site shares high amino acid conservation with MoaA and may operate on a nucleotide-like substrate 6 . These observations are consistent with the above data.
rVIP has a K m of 183 ± 28 μM for CTP and produces ddhCTP with a maximum velocity of 0.185 ± 0.007 min −1 (Fig. 1f ). The intracellular concentration of CTP typically falls in the 1 mM range, which agrees well with the K m obtained for rVIP for CTP 7 , and the rate of ddhCTP formation is consistent with that of other radical-SAM enzymes with their native substrates 8 . 5ʹ-dA and ddhCTP production is tightly coupled, with one molecule of 5ʹ-dA generated for every ddhCTP (Extended Data Fig. 3a ). rVIP also produces ddhCTP when the reaction is initiated by an enzymatic reducing system, indicating that dithionite does not direct an unanticipated side reaction between rVIP and CTP (Extended Data Fig. 3b ).
A recent report described a radical-SAM enzyme from the thermophilic fungus Thielavia terrestris (58% sequence identity to human viperin) that was capable of catalysing the coupling of UDP-glucose and 5ʹ-dA to generate an uncharacterized product with a m/z of 818.1 9 . In addition, a preliminary report suggested that viperin homologues from Methanofollis liminatans (archaea, 35% sequence identity to human viperin) and Trichoderma virens (fungi, 55% identity) catalyse the radical-based condensation of 5ʹ-dA and isopentenyl pyrophosphate to yield adenylated isopentyl pyrophosphate 10 . Substrate activation and competition assays demonstrate that mammalian viperin does not catalyse these transformations (Fig. 1a , Extended Data Fig. 3c-f ). We therefore conclude that UDP-glucose and isopentenyl pyrophosphate are not likely to be physiological substrates for mammalian viperins; although it remains a possibility that other eukaryotes use viperin homologues to perform distinct functions. Analogous competition experiments demonstrated that deoxyCTP is also not a substrate of rVIP (Extended Data Fig. 3g ).
Incubation of rVIP with SAM and CTP deuterated at the 2′, 3′, 4′, 5′ and 5 positions (deuCTP), increased the −m/z of 5ʹ-dA from 250.1 to 251.1, consistent with the transfer of one deuterium from deuCTP to 5ʹ-dA. Additionally, ddhCTP from this reaction exhibited a −m/z of 468.1, indicating that the deuterium abstracted by 5ʹ-dA did not return to the product (Extended Data Fig. 3h, 
i). Derivatives
Letter reSeArCH of site-specifically deuterated CTP demonstrated that 5ʹ-dA• initiates the reaction by uniquely abstracting the hydrogen from the 4′ position of CTP (see Supplementary Information for details, Extended Data Figs. 2, 4) . On the basis of this observation, a provisional mechanism is outlined in Fig. 2d , in which viperin uses the 5ʹ-dA• to abstract the hydrogen atom at the 4ʹ position of the ribose of CTP, subsequently allowing for the loss of the 3ʹ-hydroxyl group with general acid assistance. The resulting resonance-stabilized radical cation is then reduced by one electron to yield the designated product. This mechanism has precedent from model studies of the radiolytic cleavage of single-stranded DNA, wherein generation of a 4ʹ-deoxyribosyl radical causes heterolytic dissociation of the 3ʹ phosphate group, resulting in a 3ʹ-cation-4ʹ-yl radical 11 . The source of the additional electron needed to reduce intermediate three (or four) in the viperin-catalysed reaction is currently unclear. However, we propose that-similar to other radical-SAM enzyme reactions 12the electron probably derives from a reduced 4Fe-4S cluster, which suggests that viperin requires two electrons to complete each turnover: one to generate the 5ʹ-dA• and another to reduce intermediate three (or four).
CMPK2 is always immediately adjacent to viperin in vertebrate genomes and is co-transcribed with viperin during IFN stimulation 13 , suggesting a functional linkage. Human CMPK2 (hCMPK2) was previously reported to catalyse the ATP-dependent phosphorylation of the monophosphates CMP, UMP and dCMP to the corresponding diphosphates 14 . By contrast, we find that hCMPK2 exhibits strong preference for CDP and UDP as substrates, yielding CTP and UTP, respectively (Extended Data Fig. 5a ). Notably, when provided with ddhCDP, hCMPK2 displayed a tenfold-lower activity for producing ddhCTP when compared to the rate of CTP and UTP formation (Extended Data Fig. 5a , Supplementary Table 2 ). Therefore, on the basis of the synteny and coordinated expression of viperin and CMPK2, and the available biochemical data, we propose that CMPK2 primarily functions to ensure sufficient substrate (that is, CTP produced from CDP, or by Fig. 2 | Proposed mechanism for formation of ddhCTP. a, m/z of CTP (blue) or 4ʹ-2 H -CTP (red). b, Mass spectrometry of ddhCTP from reactions with either CTP (blue), or 4ʹ-2 H -CTP (red) and rVIP. Deuterium from 4ʹ-2 H -CTP is not retained in ddhCTP as products have the same -m/z 464.1. c, 5ʹ-dA derived from 4ʹ-2 H -CTP (red trace) increases by one mass unit owing to the incorporation of deuterium. These experiments have been repeated at least three times with similar results. d, After hydrogen atom abstraction at the 4ʹ position of CTP, general base-assisted loss of the 3ʹ hydroxyl group leads to a carbocation/radical intermediate that is reduced by one electron to yield the ddhCTP product. To demonstrate that ddhCTP can be produced in mammalian cytosol, we generated a series of human viperin (hVIP) (83% identical to rVIP) and hCMPK2 expression constructs for transient transfection in HEK293T cells (Supplemenary Table 3 , Extended Data Fig. 5b ). As HEK293T cells do not express viperin in the presence or absence of IFN 15 , ddhCTP production would not be expected in the absence of exogenous viperin expression. HEK293T cells were transfected with a control plasmid, hVIP alone, hCMPK2 alone or both hVIP and hCMPK2, and collected at defined times for LC-MS analysis (see Supplementary Information for details). In all cases, over a 72-h time course, the overall nucleotide pool consistently decreases, probably owing to limiting nutrient levels, though the overall growth and cell viability are not affected (Supplementary Table 4 ). In addition, at each time point there are no statistically significant differences in total nucleotide concentrations between the control, hVIP, and hVIP and hCMPK2 treated cells (Extended Data Fig. 6a-d ). Notably, HEK293T cells transfected with control plasmid exhibited ddhCTP levels below our limit of detection of approximately 400 fmol ( Fig. 3a , right), whereas HEK293T cells transfected with the hVIP plasmid exhibited high intracellular ddhCTP levels (approximately 75 μM at 16 h post-transfection) ( Fig. 3a, left) , which decreases to approximately 35 μM after 72 h. Cotransfection with hVIP and hCMPK2 plasmids resulted in an approximately fourfold increase in the amount of ddhCTP to approximately 330 μM at 48 h ( Fig. 3a , middle, purple, P < 0.0001). Moreover, coexpression of hVIP and hCMPK2 causes the ratio of ddhCTP to CTP concentrations to increase over time, whereas overexpression of hVIP alone results in a constant ratio of ddhCTP to CTP (Extended Data Fig. 6e ). This behaviour may enable viperin to continue generating ddhCTP even though roughly 30% of the total cellular pool of cytidine triphosphates is present as ddhCTP at 48 h. These observations demonstrate that in vivo viperin is essential for production of ddhCTP, and suggest that CMPK2 may function to ensure that CTP is not limiting in the presence of viperin.
It is well documented that viperin expression can be robustly induced in immune cells by interferon, lipopolysaccharide and double-stranded RNA analogues 16 . Therefore, we cultured immortalized murine macrophages (RAW264.7) in the presence or absence of IFNα in serumfree medium, as it has previously been shown that RAW264.7 cells express viperin in an IFNα-sensitive fashion 2 . When collected after 19 h, the concentration of ddhCTP was shown to be highly dependent on the concentration of IFNα (Extended Data Fig. 7a ). RAW264.7 cells cultured in the presence of 250 ng ml −1 IFNα generated intracellular concentrations of ddhCTP reaching nearly 350 μM, whereas the intracellular concentrations of ATP, UTP and CTP were unaltered (Extended Data Fig. 7b ). Analogous to the behaviour observed in HEK293T cells cotransfected with hVIP and hCMPK2, treatment of RAW264.7 cells with 250 ng ml −1 IFNα resulted in ddhCTP representing a sizable proportion (that is, 30%) of the total cytidine triphosphate pool (ddhCTP (approximately 350 μM) to CTP (approximately 800 μM)), whereas the level of CTP remained unchanged. This behaviour suggests that the viperin-mediated inhibition of viral replication is not a consequence of the limitation of the available pool of intracellular CTP, or other nucleotides, but rather is dependent on the generation of relevant concentrations of ddhCTP.
Because members of the flavivirus family are known to be sensitive to the catalytic activity of viperin 17 , and because of the resemblance of ddhCTP to known polymerase chain terminators, we examined the effect of ddhCTP on dengue virus RNA-dependent RNA polymerase (RdRp) activity. First, we demonstrated that ddhCTP is a substrate for dengue virus RdRp using a primed-template assay 18 (Extended Data Fig. 8a, b ). Addition of CTP, 3′-dCTP or ddhCTP led to incorporation of all of these nucleotides (Extended Data Fig. 8b ). As expected, addition of UTP to the CMP-incorporated RNA led to further extension to the end of template (Extended Data Fig. 8b , c). However, addition of UTP to the 3′-dCMP-or ddhCMP-incorporated RNA did not support robust extension (Extended Data Fig. 8b , c), as expected for the action of chain terminators. A more stringent test of the effectiveness of a chain terminator is direct competition with natural ribonucleotides. Therefore, we evaluated RNA synthesis in the presence of increasing concentrations of ddhCTP or 3′-dCTP ( Fig. 4a ). Both ddhCTP and 3′-dCTP were incorporated and inhibited production of full-length RNA (Fig. 4a ). Additionally, by titrating ddhCTP at different concentrations of CTP we determined the relative efficiency of the use of ddhCTP compared to CTP for dengue virus RdRp, as well as the RdRp from West Nile Virus (WNV), another pathogenic flavivirus ( Fig. 4b , Extended Data Fig. 8e-j) . This analysis yielded a 135-and 59-fold difference in the use of ddhCTP relative to CTP for dengue virus and WNV RdRps, respectively. We also evaluated two additional members of the flavivirus family, Zika virus (ZIKV) and hepatitis C virus RdRps. Both of these RdRps were susceptible to inhibition by ddhCTP utilization and chain termination ( Fig. 4c, d) , consistent with studies demonstrating the antiviral activity of viperin against these viruses [19] [20] [21] . These data suggest that the flavivirus RdRps would be susceptible to inhibition by ddhCTP during replication (Extended Data Fig. 9g ). Given the efficiency of use and genome size, it is calculated that even a probability of incorporating the ddhCTP chain terminator during replication of approximately 1% would result in considerable reduction of full-length genomes (Extended Data Fig. 9g ). To determine whether our observations with the flavivirus RdRps extend to RdRps from other supergroups, we evaluated members of supergroup I. Specifically, we used the RdRps from human rhinovirus type C (HRV-C) and poliovirus, which are both members of the picornavirus family (Extended Data Fig. 9 ). Direct-incorporation experiments revealed the use of both ddhCTP and 3′-dCTP by HRV-C RdRp (Extended Data Fig. 9b ). However, in the presence of other rNTPs, both HRV-C and poliovirus RdRp were poorly inhibited by ddhCTP (Extended Data Fig. 9c-f ), even though both are inhibited by 3′-dCTP. On the basis of this data, we conclude that not all RdRps are sensitive to ddhCTP, suggesting that different viruses will exhibit a range of susceptibilities to viperin expression in vivo.
The in vitro enzymatic characterizations suggest that ddhCTP would be sufficient for the in vivo inhibition of viral replication. First, we demonstrated that synthetic ddhC nucleoside was capable of traversing the plasma membrane of Vero and HEK293T cells and being metabolized to ddhCTP (1 mM synthetic ddhC resulted in the intracellular accumulation of 129 μM and 78 μM ddh-CTP after 24 h, respectively) (Extended Data Fig. 5c, d ). Next, we used the historical African strain MR766 (Uganda 1947) 22 and two contemporary strains, PRVABC59 (Puerto Rico; 2015) 23 Letter reSeArCH KX262887), to evaluate the antiviral activity of ddhC towards ZIKV replication and release from Vero cells. Treatment with ddhC resulted in a reduction in ZIKV titres of one to two orders of magnitude, which was dependent on dose, multiplicity of infection (MOI), duration of infection and strain (Supplementary Table 5 ). For example, at a MOI of 0.1, we observed 50-200-fold reduction in viral titre for ZIKV MR766 at all time points ( Fig. 5a ), with reductions of 5-50-fold also observed at a MOI of 1.0 (Extended Data Fig. 10a ). ZIKV R103451 (Honduras) and ZIKV PRVABC59 (Puerto Rico) exhibited analogous sensitivities to ddhC treatment (Supplementary Table 5 , Extended Data Fig. 10a-c) . The reduction in viral release was not a result of ddhC cytotoxicity, as incubation with 1 mM ddhC did not alter Vero cell viability (Fig. 5b , see Supplementary Information for details). These results, taken together with the in vitro enzymatic analyses, are consistent with a model in which ddhC-derived ddhCTP inhibits viral replication through premature chain termination of RdRp products. Of the hundreds of genes stimulated by IFN, most appear to function as negative effectors of viral activity, though their mechanisms of action remain to be defined. Here we propose a new paradigm for the antiviral function of viperin, which relies on its intrinsic catalytic activity to generate ddhCTP, a previously undescribed replication-chain terminator. To our knowledge, viperin is the only human protein that produces a small molecule capable of directly inhibiting viral replication machinery. Importantly, overexpression of viperin and production of ddhCTP does not appear to adversely affect the growth rate or viability of HEK293T or Vero cells. This observation indicates that the host RNA and DNA polymerases are not negatively affected by ddhCTP and have developed protective mechanisms to exclude incorporation or excise this compound during nucleic-acid synthesis; mechanistic studies on the use of ddhCTP by host polymerases will be an important area for future investigation. In addition to its inhibitory effect on viral RdRp activity, it is possible that viperin possesses additional antiviral functions. For example, despite reports that HRV infection induces viperin expression, ddhCTP does not appear to act as an effective chain terminator for the HRV RdRp 24 . Furthermore, in the case of human cytomegalovirus, viperin expression results in enhanced infectivity, possibly through alterations in cellular metabolism and disruption of the actin cytoskeleton 25 . It is probable that different pathogens are responsive to distinct subsets of the IFN-inducible genes and-given the range of modulatory effects it has on viruses-that viperin synergizes with other host-and pathogen-encoded genes.
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Extended Data Fig. 2 | NMR spectroscopy of ddhCTP. a, 13 C-13 C COSY spectrum of 13 When ddhCTP from the reaction was analysed by mass spectormetry, the product exhibited a −m/z of 468.1, indicating that the deuterium abstracted by 5′-dA during catalysis did not return to the product. The y-axis of each spectrum was normalized to 100% with arbitrary units (au) to enable direct comparison between each sample. These results have been repeated at least twice.
Extended Data Fig. 4 | Viperin abstracts the 4′-H from CTP. a-d , Using CTP with deuterium ( 2 H denoted with a red D) incorporated at either the 2′-2 H (a), 3′-2 H (b), 4′-2 H (c) or 5′-2 H 2 (d) (left column), we were able to monitor the loss of deuterium from the resulting product (middle column) and gain of a deuterium in the resulting 5′-dA (right column). The 5′-dA -m/z increases by one only in reactions containing CTP with a 4′-2 H (c, right column). Natural abundance peaks are denoted with dashed vertical lines. All experiments were repeated twice.
Extended Data Fig. 6 | Cellular concentrations of nucleotides are  not affected by viperin expression. a-d, HEK293T cells expressing Flag-hVIP (aqua), Flag-hVIP and hCMPK2 (purple) or cells only (dark blue). Samples were taken at 16, 24, 48 and 72 hours post infection (h.p.i.). Extraction performed with a mixture of acetonitrile, methanol and water (40:40:20 and 0.1 M formic acid). Cellular concentrations were determined using 13 C 9 15 N 15 -CTP, 13 C 10 15 N 10 -ATP, 13 C 10 N 5 -GTP and 13 C 9 15 N 2 -UTP spiked into the extraction mixture at known concentrations and using equations (1) and (2) in Supplementary Information. Analysis of nucleotides ATP (a), CTP (b), GTP (c) and UTP (d) did not show statistically significant differences (ns) between Flag-hVIP, Flag-hVIP and hCMPK2 or cells only for any time point. Data are from three biologically independent samples. Statistical significance was determined using a twoway ANOVA ( Supplementary Tables 12, 13, 14 and 15 ). e, Ratio of cellular concentrations of ddhCTP to CTP from HEK293T cells expressing Flag-hVIP (aqua) or Flag-hVIP and hCMPK2 (purple); samples were taken at 16, 24, 48 and 72 h post transfection. The overall ratio of ddhCTP to CTP remains constant when only Flag-hVIP is expressed, but the concentration of ddhCTP is boosted significantly relative to CTP when both Flag-hVIP and hCMPK2 are co-expressed (plots are derived from data shown in c and Fig. 3a ).
Extended Data Fig. 8 | ddhCTP is used as a substrate by dengue virus and WNV RdRp and chain terminates RNA synthesis. a, Schematic of primer-extension assay for evaluating dengue virus and WNV RdRp activity. b, Dengue virus RdRp-catalysed nucleoside incorporation using CTP, 3′-dCTP or ddhCTP as nucleoside triphosphate substrates. Some full-length product was observed in the presence of ddhCTP (more than 99% pure), which is due to residual contaminating CTP that could not be removed. c, Reaction products resolved by denaturing PAGE containing 40% formamide showing the trace amount of CTP contaminate in the ddhCTP preparation. These experiments were repeated independently at least four times with similar results. d, Longer incubation times and more dengue virus RdRp enzyme does not increase the yield of extended product. e, Dengue virus RdRp-catalysed nucleoside incorporation with increasing concentrations of ddhCTP (0, 1, 10, 100, 200 and 750 μM) at varying concentrations of CTP. This experiment was repeated independently three times with similar results. f, Plot of the percentage inhibition as a function of ddhCTP concentration at varying concentrations of CTP. Data were fit to a dose-response curve to obtain half-maximum inhibitory concentration (IC 50 ) values of ddhCTP of 60 ± 10, 120 ± 20, 520 ± 90 and 3,900 ± 700 μM at 0.1, 1, 10 and 100 μM CTP, respectively. This experiment was repeated at least three times with similar results. The total sample size is 24. The error reported is the standard error from the fit of the data to a dose-response curve. g, Plot of IC 50 values as a function of CTP concentration. The data were fit to a line with a slope of 38 ± 1 and an intercept of 91 ± 25. The error reported is the standard error from the fit of the data to a line. h, WNV RdRpcatalysed nucleoside incorporation with increasing concentrations of ddhCTP (0, 1, 10, 100, 200 and 750 μM) at varying concentrations of CTP. This experiment was repeated at least three times with similar results. i, Plot of the percentage inhibition as a function of ddhCTP concentration at varying concentrations of CTP. Data were fit to a dose-response curve to obtain IC 50 values of ddhCTP of 20 ± 10, 70 ± 10, 300 ± 40 and 2,700 ± 300 μM at 0.1, 1, 10 and 100 μM CTP, respectively. The total sample size is 24. The error reported is the standard error from the fit of the data to a dose-response curve. j, Plot of IC 50 values as a function of CTP concentration. The data were fit to a line with a slope of 27 ± 1 and an intercept of 31 ± 8. Both of these results demonstrate that once ddhCMP is incorporated, it effectively terminates synthesis and that the small amount of extended product is from a trace amount of CTP contamination. The error reported is the standard error from the fit of the data to a line. For HRV-C, the IC 50 value was estimated to be two orders magnitude greater than that calculated for dengue virus and WNV RdRps as evidenced from the data shown in d. b Calculated for a ddhCTP concentration of 350 μM using the following equation: probability = [ddhCTP]/([ddhCTP] + IC 50 ). c Calculated using the following equation: − = × − full lengthgenome(%) 100 (1 probability) C n ; in which C n is the number of cytidine residues in the viral genome with values of 2,200, 2,497, 1,565 and 1,737 for dengue virus, WNV, HRV-C and poliovirus respectively.
Extended Data Fig. 10 | ddhC reduces virus release of three different ZIKV isolates. Vero cells were treated with different concentrations of ddhC (0, 0.1 and 1 mM) for 24 h. After this 24-h period, the medium over cells was removed and cells were infected with fresh medium that contained the original concentrations of ddhC (0, 0.1 and 1 mM) and one of three strains of ZIKV; African strain MR766 (Uganda 1947), PRVABC59 (Puerto Rico; 2015) or R103451 (Honduras; 2016, GenBank: KX262887). After three hours of ZIKV infection, virus inoculum was removed and cells were treated with fresh medium that contained the original concentrations of ddhC (0, 0.1 and 1 mM). Virus samples were collected and the medium over cells was replaced with fresh medium that contained the original concentrations of ddhC at 24, 48 and 72 h.p.i. Viral titres at 24, 48 and 72 h.p.i. were determined using the plaque assay. a-c, Effect of ddhC on three different ZIKV isolates: MR766 (Uganda 1947) (a), PRVABC59 (Puerto Rico; 2015) (b) or R103451 (Honduras; 2016) (c). Analysis of ZIKV titres indicates that 1 mM ddhC inhibits all three ZIKV isolates compared to 0 mM ddhC. However, reduction in virus titre is more prominent at 24 h.p.i. and 48 h.p.i. compared to 72 h.p.i. when using an MOI of 1.0. The antiviral effect of ddhC is more prominent at an MOI of 0.1. Data are mean ± s.d. from three biologically independent samples, P values from a two-way ANOVA with Dunnett's post hoc analysis.
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